Lindbrook Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$609K Sell
8,774
-1,279
-13% -$88.8K 0.06% 195
2024
Q4
$865K Sell
10,053
-682
-6% -$58.7K 0.08% 151
2024
Q3
$1.28M Buy
10,735
+346
+3% +$41.2K 0.11% 115
2024
Q2
$1.48M Buy
10,389
+271
+3% +$38.7K 0.14% 96
2024
Q1
$1.3M Buy
10,118
+231
+2% +$29.7K 0.12% 106
2023
Q4
$1.02M Sell
9,887
-180
-2% -$18.6K 0.1% 118
2023
Q3
$915K Buy
10,067
+255
+3% +$23.2K 0.1% 113
2023
Q2
$794K Buy
9,812
+16
+0.2% +$1.3K 0.08% 137
2023
Q1
$779K Buy
9,796
+74
+0.8% +$5.89K 0.09% 131
2022
Q4
$658K Buy
9,722
+378
+4% +$25.6K 0.08% 152
2022
Q3
$465K Buy
9,344
+56
+0.6% +$2.79K 0.08% 152
2022
Q2
$517K Buy
9,288
+1,714
+23% +$95.4K 0.09% 148
2022
Q1
$421K Sell
7,574
-98
-1% -$5.45K 0.07% 180
2021
Q4
$430K Buy
7,672
+356
+5% +$20K 0.07% 180
2021
Q3
$351K Buy
7,316
+134
+2% +$6.43K 0.09% 92
2021
Q2
$301K Sell
7,182
-176
-2% -$7.38K 0.07% 122
2021
Q1
$248K Buy
7,358
+764
+12% +$25.8K 0.06% 132
2020
Q4
$230K Buy
6,594
+98
+2% +$3.42K 0.06% 128
2020
Q3
$226K Sell
6,496
-22
-0.3% -$765 0.06% 117
2020
Q2
$213K Buy
6,518
+300
+5% +$9.8K 0.06% 115
2020
Q1
$187K Sell
6,218
-1,850
-23% -$55.6K 0.07% 106
2019
Q4
$233K Sell
8,068
-112
-1% -$3.24K 0.08% 122
2019
Q3
$211K Sell
8,180
-158
-2% -$4.08K 0.08% 123
2019
Q2
$212K Buy
8,338
+402
+5% +$10.2K 0.08% 125
2019
Q1
$207K Buy
7,936
+364
+5% +$9.49K 0.08% 123
2018
Q4
$174K Buy
+7,572
New +$174K 0.09% 124